Supply Chain
Long wait times, crowded waiting rooms, and frustrated staff are often symptoms of inefficient workflows driven by physical space constraints.…
The FDA approved Vertex Pharmaceutical's third treatment for cystic fibrosis Monday, according to Reuters.
FDA Commissioner Scott Gottlieb, MD, on Tuesday outlined several initiatives the agency would take to improve patient treatments and lower healthcare costs, using resources proposed in its recent budget request.
After just 10 months at the helm, Axovant's CEO David Hung, MD, resigned Monday to "pursue other opportunities." In addition, Axovant's president and COO Marion McCourt and three board members also stepped down.
Studies backed by the National Institutes of Health contributed to the science that underlies every one of the 210 new drugs approved between 2010 and 2016, according to a new study published in the Proceedings of the National Academy of…
To protect their bottom line amid ever-increasing drug prices, most hospitals agree they must implement cost containment strategies for medication spend. However, realizing and sustaining cost savings over time is an achievement few obtain.
Scott Gottlieb, MD, stepped into his role as FDA commissioner amid much scrutiny over his deep ties to the drug and device industry. More than nine months into his leadership position, Dr. Gottlieb has managed an impressive feat for an…
Hospitals should first turn to their item master when looking to improve data management within their supply chain, according to Christopher O'Connor, author of The Healthcare Supply Chain: Best Practices for Operating at the Intersection of Cost, Quality, and Outcomes,…
The FDA on Tuesday granted premarket approval to BD's Onclarity HPV Assay.
The FDA on Tuesday approved Novartis' generic version of Teva Pharmaceutical's best-selling multiple sclerosis drug, Copaxone, reports Reuters.
Walgreens Boots Alliance is reportedly in talks to purchase the portion of AmerisourceBergen it doesn't already own — a move that could help the company in the increasingly competitive healthcare landscape, according to The Wall Street Journal.